Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Orthofix MedicalFRA:OM2 +1.75%60 Current Ratio is 2.84 as of Jun. 2026, which is 1% below its 10-year median of 2.86. GuruFocus rates FRA:OM2 with a GF Score™ of 60/100 and a GF Value™ of €12.11 (Modestly Undervalued). The stock has 6 warning signs investors should review. Among 851 Medical Devices & Instruments companies, Orthofix Medical ranks better than 57.11% on this metric.
The current ratio is a liquidity ratio that measures a company's ability to pay short-term obligations. It is calculated as a company's Total Current Assets divides by its Total Current Liabilities. Orthofix Medical's current ratio for the quarter that ended in Jun. 2026 was 2.84.
Orthofix Medical has a current ratio of 2.84. It generally indicates good short-term financial strength.
The historical rank and industry rank for Orthofix Medical's Current Ratio or its related term are showing as below:
FRA:OM2'
s Current Ratio Range Over the Past 10 Years
Min: 2.22 Med: 2.86 Max: 4.04
Current: 2.84
During the past 13 years, Orthofix Medical's highest Current Ratio was 4.04. The lowest was 2.22. And the median was 2.86.
FRA:OM2's Current Ratio is ranked better than 57.11% of 851
companies
in the Medical Devices & Instruments industry
Industry Median: 2.43
vs FRA:OM2: 2.84
Orthofix Medical (FRA:OM2) Current Ratio Explanation
The current ratio can give a sense of the efficiency of a company's operating cycle or its ability to turn its product into cash. Companies that have trouble getting paid on their receivables or have long inventory turnover can run into liquidity problems because they are unable to alleviate their obligations. Because business operations differ in each industry, it is always more useful to compare companies within the same industry.
Acceptable current ratios vary from industry to industry and are generally between 1 and 3 for healthy businesses.
The higher the current ratio, the more capable the company is of paying its obligations. A ratio under 1 suggests that the company would be unable to pay off its obligations if they came due at that point. While this shows the company is not in good financial health, it does not necessarily mean that it will go bankrupt - as there are many ways to access financing - but it is definitely not a good sign.
If all other things were equal, a creditor, who is expecting to be paid in the next 12 months, would consider a high current ratio to be better than a low current ratio, because a high current ratio means that the company is more likely to meet its liabilities which fall due in the next 12 months.
Orthofix Medical Current Ratio Related Terms
Orthofix Medical Current Ratio Historical Data
* Premium members only.
The historical data trend for Orthofix Medical's Current Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
FRA:OM2 vs VMD, VREX, KIDS: Current Ratio Comparison
For the Medical Devices subindustry, Orthofix Medical's Current Ratio, along with its competitors' market caps and Current Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Orthofix Medical Current Ratio vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Orthofix Medical's Current Ratio distribution charts can be found below:
* The bar in red indicates where Orthofix Medical's Current Ratio falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Orthofix Medical (FRA:OM2) has a Current Ratio of 2.84 as of Jun. 2026. This is near median its historical median of 2.86. Over the past decade, Orthofix Medical's Current Ratio has ranged from 2.22 to 4.04. According to the industry distribution chart, Orthofix Medical ranks #365 out of 851 companies in the Medical Devices & Instruments industry, placing it in the top 42.9%.
Is Orthofix Medical's Current Ratio too high?
Orthofix Medical's current Current Ratio of 2.84 is near median its 10-year median of 2.86. Over the past 10 years, this metric has ranged from a low of 2.22 to a high of 4.04. The Medical Devices & Instruments industry median Current Ratio is 2.43. Orthofix Medical's value of 2.84 is 16.9% above this industry median. Based on the distribution chart, Orthofix Medical ranks #365 out of 851 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Orthofix Medical has a GF Score™ of 60/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Orthofix Medical's Current Ratio compare to VMD and VREX?
According to the Medical Devices & Instruments industry distribution chart, Orthofix Medical ranks #365 out of 851 companies for Current Ratio. This puts Orthofix Medical in the upper half of its industry. The industry median Current Ratio is 2.43. Orthofix Medical's value of 2.84 is 16.9% above this benchmark. Historically, Orthofix Medical's own Current Ratio has ranged from 2.22 to 4.04 over the past decade. While the company's 10-year median is 2.86 vs. the industry median of 2.43, Orthofix Medical has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Current Ratio for a Medical Devices & Instruments company?
The median Current Ratio among Medical Devices & Instruments companies is 2.43, based on 851 companies in the industry. Companies in the top quartile (top 25%) have a Current Ratio significantly above this median, while those in the bottom quartile fall well below. However, Current Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Orthofix Medical's current Current Ratio of 2.84 is 16.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Current Ratio mean?
A high Current Ratio can signal that a stock is expensive relative to its fundamentals. For the Medical Devices & Instruments industry, the median Current Ratio is 2.43 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Orthofix Medical's current Current Ratio is 2.84, which is near median its own 10-year median of 2.86. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Orthofix Medical stock overvalued right now?
Based on GuruFocus' analysis, Orthofix Medical (FRA:OM2) is currently considered Modestly Undervalued. The stock's GF Value™ is €12.11, compared to a current price of €8.70 — trading 28.2% below its estimated fair value. The current Current Ratio is 2.84, which is near median its 10-year median of 2.86 and 16.9% above the Medical Devices & Instruments industry median of 2.43. Orthofix Medical's overall GF Score™ is 60/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Current Ratio calculated?
Current Ratio is calculated from a company's financial statements. For Orthofix Medical (FRA:OM2), the current Current Ratio is 2.84 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Orthofix Medical (FRA:OM2) Overvalued in 2026?
Based on GuruFocus' analysis, Orthofix Medical stock appears to be undervalued.
The current stock price of €8.70 is trading 28.2% below its estimated GF Value™ of €12.11.
GuruFocus considers Orthofix Medical to be Modestly Undervalued.
Key valuation signals for FRA:OM2:
Current Ratio: 2.84 (near median its 10-year median of 2.86)
GF Value™: €12.11 vs. price of €8.70 (28.2% below fair value)
Industry Position: 16.9% above the Medical Devices & Instruments median (#365 of 851)
No single metric tells the full story. See the FRA:OM2 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Orthofix Medical Inc. is a medical device company delivering orthopedic and spine solutions to healthcare providers. The company has two reportable segments: Global Spine and Global Limb Reconstruction. The Global Spine segment offers bone growth therapies, spinal implants, biologics, and enabling technologies used in spinal procedures. The Global Limb Reconstruction segment provides products and solutions for limb deformity correction, limb lengthening, fracture management, and limb preservation, supported by digital technologies. It generates the majority of its revenue from the Global Spine segment.
60GF Score
Get the complete analysis for FRA:OM2
Current Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:OM2 has been successfully added to your 
